Hemodynamic Effects of Spironolactone in Patients With Heart Failure
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
To determine if the beneficial effect of spironolactone in patients with congestive heart
failure is in part due to its intrinsic inotropic action.
Randomized, two group placebo controlled, single blind study.